Lv5
1250 积分 2024-07-03 加入
Spatial and genomic profiling of residual breast cancer after neoadjuvant chemotherapy unveil divergent fates for each breast cancer subtype
5个月前
已完结
Exploratory phase II trial of an anti-PD-1 antibody camrelizumab combined with a VEGFR-2 inhibitor apatinib and chemotherapy as a neoadjuvant therapy for triple-negative breast cancer (NeoPanDa03): efficacy, safety and biomarker analysis
5个月前
已完结
KCNJ15 deficiency promotes drug resistance via affecting the function of lysosomes
5个月前
已完结
Clinical and Biomarker Findings of Neoadjuvant Pembrolizumab and Carboplatin Plus Docetaxel in Triple-Negative Breast Cancer
5个月前
已完结
Tumor-Infiltrating Lymphocytes Refine Outcomes in Triple-Negative Breast Cancer Treated with Anthracycline-Free Neoadjuvant Chemotherapy
5个月前
已完结
The roles of plant-derived nanovesicles in malignant tumours: A bibliometric analysis
7个月前
已完结
Prognostic Value of Immunohistochemistry-based Subtyping Before and After Neoadjuvant Chemotherapy in Patients with Triple-negative Breast Cancer
7个月前
已完结
Aberrant E-cadherin Expression in Lobular Carcinoma In Situ
7个月前
已完结
Breast Carcinomas Resembling Acinic Cell Carcinoma
7个月前
已完结
Clinicopathologic and Whole Exome Sequencing Analyzes of High-Grade Serous Carcinoma-Like Carcinoma of the Breast Reveal Unique Genetic Profile and Poor Clinical Outcome
7个月前
已完结
皖公网安备34019202002308
